Prestige Brand Holdings (PBH) Stock Price, Quote & News

Company Profile

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name;...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 914 524 6800

Website: www.prestigebrands.com

Address:

660 White Plains Road, Tarrytown, United States

Estimize Jun. 19 at 12:03 PM

Wall St is expecting 1.00 EPS for $PBH Q1 [Reporting 07/31 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont

0 · Reply

ZacksResearch Jun. 11 at 1:24 PM

$PBH rallies 30.9% in a year — what’s driving the momentum? 🚀 💡 Strong e-commerce growth in fiscal 2025 and strategic acquisitions are fueling PBH’s expansion, with digital strategies boosting consumer engagement. Despite currency and unfavorable solvency headwinds, the company’s diverse brand portfolio remains robust. Discover the full growth strategy here 👉 https://www.zacks.com/commentary/2494085/should-you-continue-to-hold-prestige-consumer-stock-in-your-portfolio?cid=sm-stocktwits-2-2494085-body&ADID=SYND_STOCKTWITS_TWEET_2_2494085_BODY

0 · Reply

ZacksResearch Jun. 11 at 11:36 AM

$PBH is riding high on e-commerce and brand strength — but is it enough? The company’s growth is fueled by digital momentum and brand innovations, yet a heavy debt load and forex exposure could limit upside. Full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2494085/should-you-continue-to-hold-prestige-consumer-stock-in-your-portfolio?cid=sm-stocktwits-2-2494085-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2494085_TEASER

0 · Reply

ZacksResearch May. 27 at 1:57 PM

$PBH up 35.7% in a year — what's fueling the momentum? 🚀 ✅ Strong brand portfolio with growth in GI & Women's Health categories 🛒 Impressive growth in e-commerce channel, strategic acquisitions boosting expansion 📈 Zacks Rank #2 (Buy) with promising business segment performance Discover why PBH is a wealth creator now 👉 https://www.zacks.com/commentary/2477525/prestige-consumer-gains-357-in-a-year-whats-driving-the-stock?cid=sm-stocktwits-2-2477525-body&ADID=SYND_STOCKTWITS_TWEET_2_2477525_BODY

0 · Reply

ZacksResearch May. 27 at 11:51 AM

$PBH stock jumps on the back of brand strength, e-commerce gains and smart acquisitions despite tariff and foreign exchange headwinds. Know more: https://www.zacks.com/stock/news/2477525/prestige-consumer-gains-357-in-a-year-whats-driving-the-stock?cid=sm-stocktwits-2-2477525-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2477525_TEASER

0 · Reply

TimRegan_WTR May. 15 at 3:30 PM

$PBH

0 · Reply

research_WTR May. 15 at 2:14 PM

PBH delivered a strong 4QFY25, beating on both revenue and EPS, with broad-based growth and record free cash flow performance. 🔹 Adjusted EPS of $1.32 beat consensus and rose 29% Y/Y 🔹 Revenue grew 7% to $296.5M, driven by strong North America performance in women’s health and GI 🔹 E-commerce growth surged, aided by ~$7M in pre-tariff buying 🔹 EBITDA margin expanded 260bps to 35.2%, with $243.9M in FY25 free cash flow 🔹 Leverage ratio dropped to 2.4x; management building cash for future acquisitions or potential buybacks Prestige Consumer Healthcare strong execution and financial discipline set the stage for continued value creation in FY26. https://www.watertowerresearch.com/doc?docID=UR_PBH_05142025 $PBH #Earnings #ConsumerHealth #SmallCapSpotlight #HealthcareStocks #GrowthStrategy #FreeCashFlow #Investing #WTRInsights

0 · Reply

UncleStock May. 11 at 4:09 PM

$RPRX $PBH $ZTS $MRK suggested for $DRG US ARCA Pharmaceutical - value screen: https://zpr.io/tykPs

0 · Reply

d_risk May. 9 at 4:42 PM

$PBH - Prestige Consumer Healthcare Inc. Common Stock - 10K - Updated Risk Factors PBH’s 2025 risk factors highlight tariffs as a growing cost and demand pressure alongside inflation, labor shortages, and supply chain issues; increased economic threats from unemployment and reduced government aid; expanded regulatory and sustainability risks; heightened cybersecurity focus including AI; and updated debt and credit facility terms. #Tariffs #DebtTerms #EconomicThreats #Sustainability #RegulatoryRisks #Cybersecurity #SupplyChain #LaborShortages #Inflation 🟢 Added 🟠 Removed https://d-risk.ai/PBH/10-K/2025-05-09

0 · Reply

IN0V8 May. 9 at 3:44 PM

$PBH Canaccord Genuity raises PT to $105 from $100

0 · Reply

Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination

Jun 9, 2025, 4:30 PM EDT - 12 days ago

Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference

May 11, 2025, 6:53 AM EDT - 6 weeks ago

Prestige Consumer Healthcare Inc. (PBH) Q4 2025 Earnings Call Transcript

May 8, 2025, 7:09 AM EDT - 6 weeks ago

UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings

May 8, 2025, 6:00 AM EDT - 6 weeks ago

Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings

Apr 10, 2025, 5:00 PM EDT - 2 months ago

Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results

Feb 6, 2025, 11:02 AM EST - 4 months ago

Prestige Consumer Healthcare Inc. (PBH) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 6:00 AM EST - 4 months ago

Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook

Nov 9, 2024, 11:50 AM EST - 8 months ago

Prestige Consumer Healthcare Inc (PBH) Q2 2025 Earnings Call Transcript

Aug 8, 2024, 11:20 AM EDT - 11 months ago

Prestige Consumer Healthcare Inc. (PBH) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 6:00 AM EDT - 11 months ago

Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results

Jul 2, 2024, 4:30 PM EDT - 1 year ago

Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results

May 15, 2024, 1:15 PM EDT - 1 year ago

Prestige Consumer Healthcare Inc (PBH) Q4 2024 Earnings Call Transcript

May 14, 2024, 5:00 PM EDT - 1 year ago

Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results

Apr 25, 2024, 8:30 AM EDT - 1 year ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results

Apr 3, 2024, 11:57 AM EDT - 1 year ago

Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag

Feb 8, 2024, 2:18 PM EST - 1 year ago

Prestige Consumer Healthcare Inc. (PBH) Q3 2024 Earnings Call Transcript

Feb 8, 2024, 6:00 AM EST - 1 year ago

Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results

Feb 2, 2024, 9:00 AM EST - 1 year ago

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene

Jan 10, 2024, 5:00 PM EST - 1 year ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results

Dec 22, 2023, 9:00 AM EST - 1 year ago

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene

Nov 24, 2023, 8:30 AM EST - 1 year ago

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder Due to the Presence of Benzene

Nov 2, 2023, 6:00 AM EDT - 1 year ago

Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results

Oct 5, 2023, 4:30 PM EDT - 1 year ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results

Sep 5, 2023, 5:00 PM EDT - 1 year ago

Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference

Aug 5, 2023, 8:53 AM EDT - 2 years ago

Prestige Consumer Healthcare Inc. (PBH) Q1 2024 Earnings Call Transcript

Aug 3, 2023, 6:00 AM EDT - 2 years ago

Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results

Jul 11, 2023, 8:00 AM EDT - 2 years ago

Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results

Jul 6, 2023, 4:30 PM EDT - 2 years ago

Prestige Consumer Healthcare Publishes Inaugural Sustainability Report

Jun 5, 2023, 9:00 AM EDT - 2 years ago

Prestige Consumer Healthcare to Present at Upcoming Investor Conferences

May 31, 2023, 9:00 AM EDT - 2 years ago

Goody's® Introduces New “GET TO GOOD™” Marketing Campaign

May 23, 2023, 2:00 PM EDT - 2 years ago

Dramamine® Eases Americans' Travel Woes with ‘Ditch the Drama' Sweepstakes Offering a Vacation to Anywhere in the World

May 4, 2023, 6:00 AM EDT - 2 years ago

Prestige Consumer Healthcare Inc. Reports Record Fiscal Year 2023

Feb 2, 2023, 11:49 AM EST - 2 years ago

Prestige Consumer Healthcare Inc. (PBH) Q3 2023 Earnings Call Transcript

Feb 2, 2023, 6:00 AM EST - 2 years ago

Prestige Consumer Healthcare Inc. Reports Third Quarter Results

Jan 5, 2023, 4:30 PM EST - 2 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Third Quarter Earnings Results

Nov 6, 2022, 3:55 AM EST - 2 years ago

Prestige Consumer Healthcare Inc. (PBH) Q2 2023 Earnings Call Transcript

Nov 5, 2022, 3:59 PM EDT - 2 years ago

Premium Brands Holdings Corporation (PRBZF) Q3 2022 Earnings Call Transcript

Nov 3, 2022, 6:00 AM EDT - 2 years ago

Prestige Consumer Healthcare Inc. Reports Second Quarter Results and Reaffirms Outlook for Fiscal 2023

Oct 4, 2022, 4:30 PM EDT - 2 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Second Quarter Earnings Results

Sep 7, 2022, 5:03 PM EDT - 3 years ago

Prestige Consumer Healthcare to Present at Barclays Global Consumer Staples Investor Conference

Aug 7, 2022, 3:40 PM EDT - 3 years ago

Prestige Consumer Healthcare Inc.'s (PBH) CEO Ron Lombardi on Q1 2023 Results - Earnings Call Transcript

Aug 7, 2022, 7:13 AM EDT - 3 years ago

Premium Brands Holdings Corporation (PRBZF) CEO George Paleologou on Q2 2022 Results - Earnings Call Transcript

Aug 4, 2022, 6:00 AM EDT - 3 years ago

Prestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023

Jul 11, 2022, 4:30 PM EDT - 3 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 First Quarter Earnings Results

May 6, 2022, 12:48 PM EDT - 3 years ago

Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2022 Results - Earnings Call Transcript

May 5, 2022, 4:30 PM EDT - 3 years ago

Prestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022

Apr 14, 2022, 8:53 AM EDT - 3 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Fourth Quarter and Year-End Earnings Results

Feb 3, 2022, 2:27 PM EST - 3 years ago

Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q3 2022 Results - Earnings Call Transcript

Feb 3, 2022, 6:00 AM EST - 3 years ago

Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results

Estimize Jun. 19 at 12:03 PM

Wall St is expecting 1.00 EPS for $PBH Q1 [Reporting 07/31 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont

0 · Reply

ZacksResearch Jun. 11 at 1:24 PM

0 · Reply

ZacksResearch Jun. 11 at 11:36 AM

0 · Reply

ZacksResearch May. 27 at 1:57 PM

0 · Reply

ZacksResearch May. 27 at 11:51 AM

0 · Reply

TimRegan_WTR May. 15 at 3:30 PM

$PBH

0 · Reply

research_WTR May. 15 at 2:14 PM

0 · Reply

UncleStock May. 11 at 4:09 PM

$RPRX $PBH $ZTS $MRK suggested for $DRG US ARCA Pharmaceutical - value screen: https://zpr.io/tykPs

0 · Reply

d_risk May. 9 at 4:42 PM

0 · Reply

IN0V8 May. 9 at 3:44 PM

$PBH Canaccord Genuity raises PT to $105 from $100

0 · Reply

UncleStock May. 8 at 8:58 AM

$RPRX $PBH $ZTS $OGN suggested for $DRG US ARCA Pharmaceutical - value screen: https://zpr.io/tykPs

0 · Reply

UncleStock May. 7 at 5:58 PM

$RPRX $PBH $ZTS $OGN suggested for $DRG US ARCA Pharmaceutical - value screen: https://zpr.io/tykPs

0 · Reply

UncleStock May. 3 at 12:19 AM

$RPRX $PBH $ZTS $MRK suggested for $DRG US ARCA Pharmaceutical - value screen: https://zpr.io/tykPs

0 · Reply

NVDAMillionaire Mar. 29 at 1:31 AM

$PBH Eyeing PBH for its strong consumer healthcare lineup. Diversified portfolio looks solid. International growth catching my attention. Might add to watchlist. in-depth review of recent trends: https://beyondspx.com/article/prestige-consumer-healthcare-inc-pbh-solidifies-its-position-as-a-leading-consumer-healthcare-player

0 · Reply

UncleStock Mar. 22 at 5:44 PM

$RPRX $PBH $ZTS $PFE suggested for $DRG US ARCA Pharmaceutical - value screen: https://zpr.io/tykPs

0 · Reply

JarvisFlow Mar. 21 at 4:36 PM

RBC Capital has adjusted their stance on Prestige Consumer ( $PBH ), setting the rating to Sector Perform with a target price of 96 → 97.

0 · Reply

gggekko Mar. 7 at 12:11 AM

$PBH nice flag here PT 97 if it breakout tmrw

0 · Reply

TimRegan_WTR Mar. 6 at 4:12 PM

$PBH

0 · Reply

research_WTR Mar. 6 at 3:42 PM

Initiating Coverage on Prestige Consumer Healthcare (PBH) We’re covering Prestige Consumer Healthcare, a leading OTC health & personal care provider with strong cash flow, stable margins, and M&A potential. 🔹 FY25 EPS Estimate: $4.50 (+6.7% Y/Y), Revenue: $1.13B (+0.4% Y/Y) 🔹 Strong EBITDA Margins (~35%), supported by mid-50% gross margins & efficient cost structure 🔹 Robust free cash flow, driving debt reduction, share buybacks, & acquisitions 🔹 Track record of strategic M&A, positioning PBH for future portfolio expansion PBH’s stable revenue, high margins, and acquisition potential make it a compelling player in the OTC healthcare space. Read Douglas M. Lane, CFA's full report and subscribe at our website to follow along! https://www.watertowerresearch.com/doc?docID=IOC_PBH_02192025 $PBH #Healthcare #OTC #Earnings #NYSE #Investing #WTRInsights

0 · Reply

UncleStock Mar. 5 at 11:02 AM

$RPRX $PBH $ZTS $JNJ suggested for $DRG US ARCA Pharmaceutical - value screen: https://zpr.io/tykPs

0 · Reply

UncleStock Feb. 22 at 6:01 AM

$RPRX $PBH $ZTS $JNJ suggested for $DRG US ARCA Pharmaceutical - value screen: https://zpr.io/tykPs

0 · Reply

UncleStock Feb. 17 at 12:55 PM

$RPRX $PBH $ZTS $JNJ suggested for $DRG US ARCA Pharmaceutical - value screen: https://zpr.io/tykPs

0 · Reply

Market Cap	4.12B
Revenue (ttm)	1.14B
Net Income (ttm)	214.61M
EPS (ttm)	N/A
PE Ratio	18.42
Forward PE	17.57
Profit Margin	18.86%
Debt to Equity Ratio	0.54

Volume	362,300
Avg Vol	345,378
Day's Range	N/A - N/A
Shares Out	49.42M
Stochastic %K	14%
Beta	0.45
Analysts	Strong Sell
Price Target	$94.25